Sponsorship & Exhibits

The TERMIS 2021 World Congress offers great opportunities to both commercial and non-commercial organizations, allowing them to showcase their products and services.

The TERMIS 2021 World Congress is the premier scientific event for Tissue Engineering and Regenerative Medicine in 2021. There are no continental chapter TERMIS meetings in that year.

Please apply to exhibit and sponsorship and:

  • Present your business to an international premier scientific event for Tissue Engineering en Regenerative Medicine 2021.
  • Get in front and meet new customers – explore new business opportunities
  • Promote/market your business/services

For questions with regard to the exhibition and sponsorships, please contact the Congress Secretariat:
Klinkhamer Group | conferences & events
Ms. Nadia Debie

Tel.: +31 43 362 7008
Email: info@termis2021.org

Stand 4: Dunn Labortechnik GmbH
Stand 6: Reserved/optionally booked
Stand 9: Nadir tech
Stand 12: Tissuelabs
Stand 20: Merck
Stand 28: Manchester BIOGEL
Stand 29: Reserved/optionally booked
Stand 30: Cellink
Stand 31: Readily3D
Stand 32: Lifecore Biomedical 
Stand 34: Reserved/optionally booked
Stand 40: Rousselot

Stand 41: Reserved/optionally booked

Rousselot

At Rousselot we have drawn upon our 130 years of worldwide expertise and a proven track record of pharmaceutical gelatins to develop X-Pure®. A range of purified gelatins specifically designed for (bio)medical applications. 

X-Pure is the first complete range of highly purified gelatins with endotoxin levels below 10 EU/g. Endotoxins are pyrogens and when present in a biomaterial can cause febrile responses. Endotoxins are extremely resistant to temperature and difficult to remove by conventional methods. Thanks to Rousselot®’s proprietary purification process, X pure has shown to have a reduced pyrogenic activity reducing potential immune reactions.

Discover X-Pure GelMA, the latest addition to X-Pure portfolio
Gelatin can be modified with Methacryloyl to form GelMA which can be crosslinked to increase mechanical strength and prevent melting of gelatin-based constructs. In GelMA hydrogels, the inherent bioactivity, biodegradability, and cell compatibility of gelatin are combined with the tunability of photo-crosslinking. This combination holds a great potential for the creation of made-to-measure biological environments for the culture of various eukaryotic cells at body temperature.
X-Pure GelMA offers ultra-high purity level and will be available in both research grade & GMP grade, with all necessary documentation for approval by regulatory authorities worldwide.

Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help you “Advance medical science”. With a proven track record of gelatin and collagen specifically used in pharmaceutical applications, Rousselot is recognized for its global expertise. 

Website: www.rousselot.com/biomedical

Manchester BIOGEL

Manchester BIOGEL is a leader in the design and manufacture of 3D synthetic peptide hydrogels that are redefining cell culture and 3D bioprinting for life science. Our biologically relevant PeptiGels® and PeptiInks® mimic the cell micro-environment and have tuneable properties to simulate the natural environment of all human tissues. Our PeptiGels® are specifically designed and tailored to overcome the key limitations with current biomaterials for regenerative medical applications. Our PeptiInks® are specifically designed to encapsulate and print cells with precise structural definition. Everything is 100% ethical, animal free and chemically defined, and are supplied with no batch-to-batch variability. This gives you the confidence to achieve reliable and consistent results every time, and with the adage of being clinically translatable, you have the potential to deliver life-changing therapies.

Website: www.manchesterbiogel.com 

Merck 

WE ARE MERCK
Our pursuit is progress for people everywhere. That's why we take a closer look at things, ask questions and think ahead.
We've been around for more than 350 years, yet our majority owners are still the descendants of Friedrich Jacob Merck, the man who founded our company in Darmstadt, Germany in 1668.
Since then, we have become a truly global company. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live.
From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of € 16.2 billion in 66 countries.
We are Merck. The only exceptions are the United States and Canada. Here we operate as EMD Serono in the Biopharma business, as MilliporeSigma in the Life Science business, and as EMD Performance Materials in the materials business.

OUR LIFE SCIENCE BUSINESS ACCELERATES ACCESS TO HEALTH FOR PEOPLE EVERYWHERE.
We provide infinite solutions to solve the toughest problems in life science in collaboration with the global scientific community. Our tools, services and digital platforms empower scientists and engineers at every stage, helping deliver breakthrough therapies more quickly.

Website: https://www.sigmaaldrich.com

Cellink Life Sciences 

Founded in 2016, CELLINK is a global life-science company that provides technologies, products and services to create, understand and master biology. With a focus on the application areas of bioprinting, analysis, and liquid handling and bioprocessing, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries. CELLINK’s products are trusted by more than 1,800 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 60 countries, and have been cited in more than 200 publications. CELLINK is creating the future of medicine.

Website: www.cellink.com

Dunn Labortechnik 

More information will be available soon. 

Website: www.dunnlab.de

Lifecore Biomedical

Do you need a source of Pharmaceutical Grade Sodium Hyaluronate for your TERM research and product development? For over 35 years, our hyaluronan has improved the lives of more than 100 million patients. Lifecore’s pharmaceutical grade hyaluronan is produced by bacterial fermentation in its U.S. based FDA registered/ISO 13485 certified-facility. Lifecore offers convenient quantities of sodium hyaluronate over a broad range of average molecular weights (5,000 Da. to 3M Da.) All its research lots of sodium hyaluronate are derived from pharmaceutical lots, are lot traceable, and come with a certificate of analysis.
Do you need the characteristics of hyaluronan in a longer lasting form? Lifecore’s Corgel® BioHydrogel is a biocompatible cross-linked hydrogel which is highly tunable for use in 3D constructs and cultures. Its low density tyramine based cross-linking reaction is gentle and biocompatible allowing for in situ cross-linking.
Do you have a viscous or difficult to fill TERM product that needs aseptic filling? Lifecore brings over 30 years of experience aseptically filling challenging injectable solutions in a cGMP environment.
Have you had a difficult time finding a contract manufacturer with Viscous Solutions experience? Our reliability and commitment is proven through the long-standing duration of our partnerships. Our partners are market leaders in several diverse medical segments.
How can we assist you in overcoming your challenges and realize your market opportunities? Visit us at our booth to learn more about our sodium hyaluronate and cGMP pharmaceutical compliant aseptic filling capabilities or contact Rebecca at rebecca.sebasky@lifecore.com or 952-368-6321.

Website: www.lifecore.com

Nadir Plasma and Polymers

Nadir Plasma and Polymers is an R&D company with more than 10 years experience in two innovative technologies: 

A Cold Atmospheric Plasma (CAP) proprietary technology for surface avctivation and cleaning, sterilization, and functional coating deposition.
A Clean Melt Compounding technology for the production of bioactive polymers obtained by mean of innovative smart fillers introduction.
Thanks to these two technologies we are able to provide surface modifications on every materials and bulk modification on all thermoplastic polymers of your interest.
Today, for the tissue engineering and regenerative medicine community we are providing the following innovative solutions:

At the surface, by mean of our atmospheric plasma jet device, we allow you to sterilize and improve surface wettability, adhesion between materials and molecules and to modify the surface of your interest with specific chemical functionalities able to steer cell growth. Polymeric and ceramic thin film deposition are also possible.

In the polymer bulk, by mean of our clean melt compounding technology, we are providing, custom bioactive polymer compounds like PCL/rGO, PCL/HA, PLA/HA, PEOTPBT and PolyActive ™ with active pharmaceutical ingredients (API) and other polymer compound realized on demand starting from different bioresorbable polymer and bioactive fillers . These bioactive materials will allow to realize additive manufactured parts with antimicrobial properties, cell growth differentiation properties, bone minerals properties and electroconductive properties.

Finally, both technologies can be combined in 3D printing platforms to allow our customers to print advance polymer with intrinsic regenerative properties. 3D printing platforms, then, can  be equipped with our plasma module in order to modify the surfaces of interest during the 3D printing process.

Website: www.nadir-tech.it 

Readily3D

Readily3D helps biologists push the frontiers of biofabrication. Our volumetric bioprinter, Tomolite, leverages a contactless tomographic illumination technology to shape sensitive cells and biomaterials into biological systems, without impairing their viability. Volumetric printing not only preserves cells but also makes research more efficient by simplifying design iterations and statistical studies. Reach out to us to know more!

Website: www.readily3d.com

 

TissueLabs 

TissueLabs is the platform for creating organs and tissues in the lab.

Our ECM-based hydrogels, MatriXpec™, are developed to offer tissue-specific microenvironments for 3D cell culture and 3D bioprinting. MatriXpec™ hydrogels allow running experiments in truly representative substrates that mimic the biological clues of the native extracellular matrix. They are available for 16 different tissues: Adipose, Bone, Brain, Cartilage, Colon, Intestine, Kidney, Liver, Lung, Muscle, Myocardium, Pancreas, Skin, Spleen, Stomach, and Vascular. Besides the conventional thermocrosslinkable MatriXpec™, we also offer it in combination with gelatin methacrylate (GelMA) - allowing photocrosslinking - and alginate/xanthan - allowing chemical crosslinking.

For those working with epithelial tissues, we offer our proprietary platform, MatriWell™, cell culture inserts were designed for fabricating 3D epithelial barriers in vitro. They contain a hydrogel with tissue-specific extracellular matrix proteins so that when cells are cultured on MatriWell™ they are exposed to an air interface on their top and a near-liquid interface on their bottom, an "air-gel interface". This setup mimics the exact microenvironment cells would find in the native tissue. 

Thinking about the researchers willing to start working with 3D bioprinting, we developed TissueStart™, the most cost-effective 3D bioprinter on the market. TissueStart™ is constructed with premium plexiglass for high resistance, long durability, and easy cleaning. It weighs only 3.6kg and does not require air compressors to operate, presenting the smallest footprint on the market. TissueStart™ is also the only 3D bioprinter offering our exclusive Mixtrusor™ system for combining multiple bioinks, allowing the fabrication of complex 3D tissues

Website: www.tissuelabs.com